Medica Group PLC
Director / PDMR Transaction and Shareholding
Medica Group PLC (LSE: MGP, "Medica" or the "Company"), has received notification from Mr Kevin Terrins, Director of Business Development, that on 3 December 2020 he transferred a total of 1,200,000 ordinary shares of 0.2p in the Company ("Shares") to his partner, Karen Freeburn, for nil consideration.
Following this transaction, there has been no change in the number of shares in which Kevin Terrins has an interest.
The Notification of Dealing Forms can be found below.
The notifications set out below are provided in accordance with the requirements of the EU Market Abuse Regulation and set out more details of the transactions.
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
|||||
a)
|
Name |
Kevin Terrins |
||||
2
|
Reason for the notification
|
|||||
a)
|
Position/status
|
Director of Business Development |
||||
b)
|
Initial notification /Amendment
|
Initial notification |
||||
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|||||
a)
|
Name
|
Medica Group PLC |
||||
b)
|
LEI
|
213800B8XE5FUSZF5Z16 |
||||
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||
a)
|
Description of the financial instrument, type of instrument |
Ordinary shares of 0.2p
GB00BYV24996 |
||||
|
|
|||||
b)
|
Nature of the transaction
|
Transfer of Ordinary Shares to Karen Freeburn |
||||
c) |
Price(s) and volume(s)
|
|
||||
d)
|
Aggregated information - Aggrated volume - Price
|
1,200,000 N/A
|
||||
e)
|
Date of the transaction
|
3 December 2020 |
||||
f)
|
Place of the transaction
|
Outside a trading venue |